查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1565678

胸膜痛治療市場，按診斷、治療、管理模式、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Pleurodynia Treatment Market, By Diagnosis, By Treatment, By Mode of Administration, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 288 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023年，胸痛治療市場規模為1.309億美元，2024年至2032年複合年成長率為5.90%。

胸膜痛治療市場-市場動態

由於病毒感染增加，胸膜痛病例的發生率上升。

胸膜痛通常由柯薩奇病毒等病毒感染引起，由於病毒感染的增加，病例數增加。這一趨勢反映在胸膜痛治療市場上，隨著越來越多的病例被診斷和管理，該市場也在不斷成長。病毒感染，尤其是在寒冷季節流行的病毒感染，會導致胸膜痛的發生率增加。

世界衛生組織 (WHO) 透過其全球健康估算提供相關資料。根據他們的 2021 年報告，病毒感染，包括引起胸膜痛的病毒感染，在過去十年中顯著增加。具體而言，2010 年至2020 年間，導致胸膜痛等呼吸道症狀的病毒感染發生率上升了約20%。市場的擴張。

胸膜痛治療市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 5.90% 左右的複合年成長率成長

根據診斷類型細分，預計血液檢測將在 2023 年顯示最大的市場佔有率

根據治療細分，止痛藥和止痛藥是 2023 年的主要類型

依給藥方式細分，2023年口服藥物為主導類型

按地區分類，北美是 2023 年的主要收入來源

胸膜痛治療市場-細分分析：

全球胸膜痛治療市場根據診斷、治療、給藥模式、最終用戶和地區進行細分。

根據診斷型血液檢查、培養檢查和X光檢查，市場分為三類。在胸膜痛治療市場中，血液檢查是最重要的診斷部分。這種重要性是由於它們能夠識別通常引起胸膜痛的潛在病毒或細菌感染。血液檢查可以揭示發炎和感染的標記物，這對於診斷胸膜痛並將其與其他類似病症區分開來至關重要。雖然也使用培養測試和 X光，但血液檢查可以提供更直接和可操作的見解，使其成為診斷過程的核心並指導適當的治療策略。

根據治療止痛藥或止痛藥免疫球蛋白將市場分為兩類在胸膜痛治療市場中，止痛藥或止痛藥是最重要的治療部分。這種突出源於它們在控制與胸膜痛相關的嚴重疼痛方面的主要作用，這對於緩解患者症狀和提高生活品質至關重要。鎮痛藥可以有效緩解急性不適，讓患者恢復得更舒適。雖然免疫球蛋白可用於針對潛在的病毒原因，但止痛藥的使用更為廣泛，可以直接解決對患者影響最大的症狀，使其成為主要的治療選擇。

胸膜疼痛治療市場 - 地理洞察

在北美，由於人們認知的提高和醫學的進步，胸膜痛治療市場正在經歷顯著成長。病毒感染是胸膜痛的常見原因，其流行正在推動對有效治療的需求。美國和加拿大引領市場，高度重視研究和發展以增強治療選擇。成熟的醫療保健基礎設施的存在和醫療保健支出的增加有助於市場擴張。此外，不斷成長的老年人口更容易受到這種情況的影響，進一步推動了市場的成長。儘管如此，治療費用高昂以及需要對治療效果進行更全面的臨床研究等挑戰仍然存在。

胸膜痛治療市場-競爭格局：

胸膜痛治療市場競爭格局的特點是存在幾個積極參與療法開發和商業化的關鍵參與者。諾華製藥公司、輝瑞公司和葛蘭素史克公司等主要製藥公司利用其廣泛的研究能力和市場影響力，在這一領域表現突出。勃林格殷格翰有限公司和阿斯特捷利康公司也是重要貢獻者，專注於創新治療解決方案並擴大其診斷產品組合。默克公司和強生公司是為市場帶來強大治療選擇的關鍵參與者。此外，禮來公司、賽諾菲公司和艾伯維公司等公司因其對新療法開發和策略市場定位的貢獻而聞名。這些公司透過持續的研究、臨床試驗和引入新療法來推動競爭，旨在解決胸膜痛患者未滿足的需求。

最新進展：

2023 年1 月，在verywellhealth（一個線上獲獎資源，提供一系列健康相關主題的可靠和事實資訊）的一篇文章中，患者可以使用布洛芬（Advil）等非類固醇抗發炎藥來控制與胸膜痛相關的疼痛。此外，他們建議在受影響的區域使用熱敷袋也可能有助於緩解疼痛。

目錄

第 1 章：胸膜痛治療市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 胸膜痛治療市場片段（依診斷）
    • 胸膜痛治療市場片段（依治療）
    • 依管理模式分類的胸膜痛治療市場片段
    • 胸膜痛治療市場片段（依技術）
    • 按國家/地區分類的胸膜痛治療市場片段
    • 按地區分類的胸膜痛治療市場片段
  • 競爭洞察

第 3 章：胸膜痛治療主要市場趨勢

  • 胸膜痛治療市場促進因素
    • 市場促進因素的影響分析
  • 胸膜痛治療市場限制
    • 市場限制影響分析
  • 胸膜痛治療市場機會
  • 胸膜痛治療市場未來趨勢

第 4 章：胸膜痛治療產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：胸膜痛治療市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：胸膜痛治療市場格局

  • 2023 年胸膜痛治療市佔分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：胸膜痛治療市場 - 透過診斷

  • 概述
    • 透過診斷進行細分市場佔有率分析
    • 驗血
    • 文化測試
    • X光

第 8 章：胸膜痛治療市場 - 按治療分類

  • 概述
    • 按處理方式分類的細分市場佔有率分析
    • 鎮痛藥或止痛藥
    • 免疫球蛋白

第 9 章：胸膜痛治療市場 - 按給藥方式

  • 概述
    • 按管理模式分類的細分市場佔有率分析
    • 口服
    • 注射或輸液

第 10 章： 胸膜痛治療市場 - 由最終用戶

  • 概述
    • 按處理方式分類的細分市場佔有率分析
    • 醫院
    • 藥局
    • 其他

第 11 章：胸膜痛治療市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美胸膜痛治療主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模及預測（按診斷）
    • 北美市場規模與預測（以不同處理方式）
    • 北美市場規模與預測（按管理模式）
    • 北美市場規模和預測（按技術）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲胸膜痛治療主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（透過診斷）
    • 歐洲市場規模與預測（按處理方式）
    • 歐洲市場規模與預測（按管理模式）
    • 歐洲市場規模與預測（按技術）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區胸膜痛治療主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模及預測（依診斷）
    • 亞太地區市場規模與預測（以不同處理方式）
    • 亞太地區市場規模與預測（依管理模式）
    • 亞太地區市場規模與預測（按技術）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲胸膜痛治療主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按診斷）
    • 拉丁美洲市場規模與預測（以不同處理方式）
    • 拉丁美洲市場規模與預測（按管理模式）
    • 拉丁美洲市場規模與預測（按技術）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲胸膜痛治療主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按診斷）
    • 中東及非洲市場規模及預測（依不同處理方式）
    • 中東和非洲市場規模及預測（依管理模式）
    • 中東和非洲市場規模及預測（按技術）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 12 章：主要供應商分析-胸膜痛治療產業

  • 競爭儀表板
  • 公司簡介
    • Novartis Pharmaceuticals Corporation
    • Pfizer Inc.
    • GlaxoSmithKline plc
    • Boehringer Ingelheim GmbH
    • AstraZeneca plc
    • Merck & Co., Inc.
    • Johnson & Johnson
    • Eli Lilly and Company
    • Sanofi
    • AbbVie Inc.
    • Roche Holding AG
    • Takeda Pharmaceutical Company Limited
    • Mylan NV
    • Amgen Inc.
    • Bristol-Myers Squibb Company

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV3888

REPORT HIGHLIGHT

The Pleurodynia Treatment Market size was valued at USD 130.90 Million in 2023, expanding at a CAGR of 5.90% from 2024 to 2032.

Pleurodynia is a condition characterized by sharp, stabbing pain in the chest due to inflammation of the pleura, the membrane surrounding the lungs. It often results from viral infections, such as those caused by the Coxsackievirus. Treatment typically focuses on relieving pain and addressing the underlying cause. Over-the-counter pain relievers like ibuprofen or acetaminophen are commonly used, alongside rest and sometimes corticosteroids for more severe cases. The market for pleurodynia treatment includes pharmaceutical companies developing pain management medications and diagnostic tools, as well as healthcare providers offering tailored treatment plans.

Pleurodynia Treatment Market- Market Dynamics

Rising incidence of pleurodynia cases due to increased viral infections.

Pleurodynia, often caused by viral infections such as coxsackievirus, has seen a rise in cases due to an increase in viral infections. This trend is reflected in the Pleurodynia Treatment market, which is growing as more cases are diagnosed and managed. Viral infections, particularly those prevalent in colder seasons, contribute to the increased incidence of pleurodynia.

The World Health Organization (WHO) provides relevant data through its Global Health Estimates. According to their 2021 report, viral infections, including those causing pleurodynia, have seen a significant increase over the past decade. Specifically, the incidence of viral infections causing respiratory symptoms, including pleurodynia, rose by approximately 20% between 2010 and 2020. This rise in cases emphasizes the growing need for effective treatments and interventions, driving the pleurodynia treatment market's expansion.

Pleurodynia Treatment Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.90% over the forecast period (2024-2032)

Based on Diagnosis type segmentation, Blood tests was predicted to show maximum market share in the year 2023

Based on Treatment segmentation, Analgesics, and pain killers was the leading type in 2023

Based on Mode of Administration segmentation, Oral Medicines was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Pleurodynia Treatment Market- Segmentation Analysis:

The Global Pleurodynia Treatment Market is segmented on the basis of Diagnosis, Treatment, Mode of Administration, End-User, and Region.

The market is divided into three categories based on Diagnosis type Blood test, culture test, and X-ray. In the pleurodynia treatment market, blood tests are the most significant diagnostic segment. This prominence is due to their ability to identify underlying viral or bacterial infections that commonly cause pleurodynia. Blood tests can reveal markers of inflammation and infection, which are crucial for diagnosing and differentiating pleurodynia from other similar conditions. While culture tests and X-rays are also used, blood tests provide more immediate and actionable insights, making them central to the diagnostic process and guiding appropriate treatment strategies.

The market is divided into two categories based on Treatment Analgesics or Painkillers Immunoglobulin In the pleurodynia treatment market, analgesics or painkillers are the most significant treatment segment. This prominence stems from their primary role in managing the severe pain associated with pleurodynia, which is essential for patient relief and quality of life. Analgesics address the acute discomfort effectively, allowing patients to recover more comfortably. While immunoglobulins may be used to target underlying viral causes, analgesics are more widely utilized and directly address the symptom that most affects patients, making them the dominant treatment option.

Pleurodynia Treatment Market- Geographical Insights

In North America, the pleurodynia treatment market is experiencing notable growth due to increasing awareness and advancements in medicine. The prevalence of viral infections, which are a common cause of pleurodynia, is driving demand for effective treatments. The United States and Canada lead the market, with a high focus on research and development to enhance treatment options. The presence of established healthcare infrastructure and the rise in healthcare expenditure contribute to market expansion. Moreover, the growing geriatric population, which is more susceptible to such conditions, further fuels market growth. Despite this, challenges such as high treatment costs and the need for more comprehensive clinical studies on treatment efficacy remain.

Pleurodynia Treatment Market- Competitive Landscape:

The competitive landscape of the pleurodynia treatment market is characterized by the presence of several key players who are actively involved in the development and commercialization of therapies. Major pharmaceutical companies like Novartis Pharmaceuticals Corporation, Pfizer Inc., and GlaxoSmithKline plc are prominent in this space, leveraging their extensive research capabilities and market reach. Boehringer Ingelheim GmbH and AstraZeneca plc are also significant contributors, focusing on innovative treatment solutions and expanding their Diagnosis portfolios. Merck & Co., Inc. and Johnson & Johnson are key players that bring robust therapeutic options to the market. Additionally, companies such as Eli Lilly and Company, Sanofi, and AbbVie Inc. are notable for their contributions to the development of new treatments and strategic market positioning. These companies drive competition through ongoing research, clinical trials, and the introduction of novel therapies, aiming to address the unmet needs of patients with pleurodynia.

Recent Developments:

In January 2023, in an article on verywellhealth, an online award-winning resource that offers reliable and factual information on a range of health-related topics, patients can manage their pleurodynia-related pain with nonsteroidal anti-inflammatory drugs such as ibuprofen (Advil), even though there isn't a specific treatment for the condition. Additionally, they proposed that applying warm packs to the afflicted area might also aid in pain relief.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PLEURODYNIA TREATMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Novartis Pharmaceuticals Corporation
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Boehringer Ingelheim GmbH
  • AstraZeneca plc
  • Merck & Co., Inc.
  • Johnson & Johnson
  • Eli Lilly and Company
  • Sanofi
  • AbbVie Inc.
  • Roche Holding AG
  • Takeda Pharmaceutical Company Limited
  • Mylan N.V.
  • Amgen Inc.
  • Bristol-Myers Squibb Company

GLOBAL PLEURODYNIA TREATMENT MARKET, BY DIAGNOSIS TYPE- MARKET ANALYSIS, 2019 - 2032

  • Blood test
  • Culture test
  • X-ray

GLOBAL PLEURODYNIA TREATMENT MARKET, BY TREATMENT- MARKET ANALYSIS, 2019 - 2032

  • Analgesics or Painkillers
  • Immunoglobulin

GLOBAL PLEURODYNIA TREATMENT MARKET, BY MODE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Oral
  • Injections or infusion

GLOBAL PLEURODYNIA TREATMENT MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Pharmacy
  • Others

GLOBAL PLEURODYNIA TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Pleurodynia Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Pleurodynia Treatment Market Snippet by Diagnosis
    • 2.1.2. Pleurodynia Treatment Market Snippet by Treatment
    • 2.1.3. Pleurodynia Treatment Market Snippet by Mode of Administration
    • 2.1.4. Pleurodynia Treatment Market Snippet by Technology
    • 2.1.5. Pleurodynia Treatment Market Snippet by Country
    • 2.1.6. Pleurodynia Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Pleurodynia Treatment Key Market Trends

  • 3.1. Pleurodynia Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Pleurodynia Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Pleurodynia Treatment Market Opportunities
  • 3.4. Pleurodynia Treatment Market Future Trends

4. Pleurodynia Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Pleurodynia Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Pleurodynia Treatment Market Landscape

  • 6.1. Pleurodynia Treatment Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Pleurodynia Treatment Market - By Diagnosis

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Diagnosis, 2023 & 2032 (%)
    • 7.1.2. Blood test
    • 7.1.3. Culture test
    • 7.1.4. X-ray

8. Pleurodynia Treatment Market - By Treatment

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Treatment, 2023 & 2032 (%)
    • 8.1.2. Analgesics or Painkillers
    • 8.1.3. Immunoglobulin

9. Pleurodynia Treatment Market - By Mode of Administration

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Mode of Administration, 2023 & 2032 (%)
    • 9.1.2. Oral
    • 9.1.3. Injections or infusion

10. Pleurodynia Treatment Market - By End Users

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Treatment, 2023 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Pharmacy
    • 10.1.4. Others

11. Pleurodynia Treatment Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Pleurodynia Treatment Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Pleurodynia Treatment Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Pleurodynia Treatment Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Pleurodynia Treatment Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Pleurodynia Treatment Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Pleurodynia Treatment Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Novartis Pharmaceuticals Corporation
    • 12.2.2. Pfizer Inc.
    • 12.2.3. GlaxoSmithKline plc
    • 12.2.4. Boehringer Ingelheim GmbH
    • 12.2.5. AstraZeneca plc
    • 12.2.6. Merck & Co., Inc.
    • 12.2.7. Johnson & Johnson
    • 12.2.8. Eli Lilly and Company
    • 12.2.9. Sanofi
    • 12.2.10. AbbVie Inc.
    • 12.2.11. Roche Holding AG
    • 12.2.12. Takeda Pharmaceutical Company Limited
    • 12.2.13. Mylan N.V.
    • 12.2.14. Amgen Inc.
    • 12.2.15. Bristol-Myers Squibb Company

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us